Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy Optimisation Study of Adaptive Pudendal Neuromodulation in Women With Urinary Incontinence Implanted With the Amber UI System.

NCT06597994 is registered in ClinicalTrials.gov with Amber Therapeutics Ltd as lead sponsor.

NCT NCT06597994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06597994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy Optimisation Study of Adaptive Pudendal Neuromodulation in Women With Urinary Incontinence Implanted With the Amber UI System.
Lead sponsor
Amber Therapeutics Ltd
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 15, 2025
Completion date
January 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urinary incontinence